This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Blue Health Intelligence® Creates An "Informatics Center Of Excellence" Through Acquisition Of Intelimedix

Acquisition of analytics firm will expand BHI's capabilities to provide data-driven healthcare solutions

CHICAGO, Jan. 8, 2012 /PRNewswire-USNewswire/ --  Blue Health Intelligence (BHI), a leading healthcare data and analytics company, has announced that it has acquired Intelimedix, a healthcare analytics firm specializing in employer group and payer reporting solutions.

"With this acquisition, BHI will expand its business and create an Informatics Center of Excellence for Blue Cross and Blue Shield companies that will deliver solutions and best practices to support Affordable Care Act readiness," said Swati Abbott, CEO of BHI.  "The strength of the BHI data assets and resources, combined with the expanded expertise that Intelimedix brings, will allow BHI to provide the Blue Cross and Blue Shield System with the  data and analytics needed to improve the healthcare experience for consumers."

BHI brings together the healthcare industry's largest and most comprehensive database, containing integrated medical and pharmacy claims from more than 110 million individuals in a safe and secure database.  Through the use of the database, BHI builds analytic solutions such as plan and employer reporting, trends and benchmarks that inform business decisions.

Today, BHI's analytics capabilities can identify a wide-range of solutions that can help raise quality standards and manage rising healthcare costs. The addition of Intelimedix's workflow automation, enterprise architecture and cost containment capabilities will enable BHI to build new solutions that help its clients manage financial and medical risk.

"Customized for the healthcare industry, Intelimedix provides a complete analytics and business intelligence environment that will empower BHI and the entire Blue System with a full suite of web-based analytic and data-mining capabilities," said David Robinson founder of Intelimedix.

For more information about Blue Health Intelligence please visit www.bluehealthintelligence.com.

About Blue Health IntelligenceBlue Health Intelligence (BHI®) is the nation's premiere health intelligence resource, delivering data-driven insights about healthcare trends and best practices, resulting in healthier lives and more affordable access to safe and effective care. BHI accesses healthcare claims data from more than 110 million individuals nationwide, collected over seven years, in a safe, HIPAA compliant and secure database. The resulting conformed, reliable data set has the broadest, deepest pool of integrated medical and pharmacy claims, reflecting medical utilization in every ZIP code. Blue Health Intelligence (BHI) is a trade name of Health Intelligence Company, LLC. BHI is an Independent Licensee of the Blue Cross and Blue Shield Association. For more information, visit http://www.bluehealthintelligence.com/.

About IntelimedixIntelimedix is a leading provider of market-differentiating solutions in healthcare analytics. Our customizable solutions in employer group reporting, mass customized communications, medical cost containment and outsourced analytics are powered by a common analytic platform that offers previously unattainable levels of capability, speed and accuracy, with direct applicability to Accountable Care Organizations, Third Party Administrators (TPAs), employers/brokers, providers, State Exchanges, health and wellness program providers and consumers. To learn more, visit the website at http://www.intelimedix.com.

SOURCE Blue Health Intelligence

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs